Cargando…
Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
Introduction: Advanced non-small cell lung cancer (NSCLC) is traditionally treated with platinum-based chemotherapy and radiotherapy. Since immunotherapy holds promise for treating advanced NSCLC, we assessed the systemic effects of the traditional therapies for NSCLC on immune cell composition and...
Autores principales: | Talebian Yazdi, Mehrdad, Schinkelshoek, Mink S., Loof, Nikki M., Taube, Christian, Hiemstra, Pieter S., Welters, Marij J. P., van der Burg, Sjoerd H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214754/ https://www.ncbi.nlm.nih.gov/pubmed/28123900 http://dx.doi.org/10.1080/2162402X.2016.1255393 |
Ejemplares similares
-
Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2015) -
The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma
por: Yazdi, Mehrdad Talebian, et al.
Publicado: (2015) -
Detection and functional assessment of regulatory T cells in clinical samples
por: Santegoets, Saskia, et al.
Publicado: (2014) -
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
por: Welters, Marij J. P., et al.
Publicado: (2020) -
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer
por: Verdegaal, Els M E, et al.
Publicado: (2023)